About
VoxNeuro is a Canadian neuroscience and health technology company dedicated to objective brain health assessment through advanced EEG-based neuroimaging and cognitive testing. Founded by James Connolly and Kimberly Elliott, the company aims to enhance brain health management globally by providing precise insights into cognitive function. The core offering is the Cognitive Health Assessment™, a Software as a Medical Device that combines neuropsychological tests with EEG-based software to deliver rapid, objective scores of brain function. This assessment generates user-friendly reports that assist healthcare providers in making informed clinical decisions and tracking brain health over time. VoxNeuro's technology is protected by a U.S. patent and is actively expanding its product pipeline through clinical programs targeting various neurological conditions, collaborating with leading medical institutions. Headquartered in Hamilton, Ontario, VoxNeuro is led by CEO Jason Flowerday. The company is positioned as a data-driven innovator in brain health, focusing on objective measurement of cognitive function to improve understanding and treatment of neurological and psychiatric conditions.
Technologies
Keywords
Company Information
-
Employees 9
-
Founded 2017
-
Total Funding $6306196
Location
1 Broadway, Cambridge, Massachusetts, United States, 02142-1100
